AstraZeneca Pharma India Limited

Web: astrazenecaindia.com NSE: ASTRAZEN BSE: 506820 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

6976 36(1%)

Near 52W Low of 6886

Volume

4k as on 03, Sep

Open

8,950

High

9,060

Low

8,936

6,940

VWAP

6,912

52 Week High

9,850

52 Week Low

6,886

Viand Research Rating

Quality Score

18/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

17,440

No. of Shares

2.5

P/E

198.67

P/B

23.96

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.06

ROCE

Profit Growth

Listing Date

04-May-01

Promoter Holding

75%

FII Holding

2.68%

DII Holding

6.08%

Price Chart

Price Performance

1 Week3%

1 Month16%

3 Months19%

6 Months21%

1 Year24%

YTD21%

Moving Average

5 Day SMA6,957

10 Day SMA7,087

20 Day SMA7,442

30 Day SMA7,672

50 Day SMA7,865

61 Day SMA7,966

80 Day SMA8,114

200 Day SMA8,430

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	7,032	6,897	6,986	7,026
Resistance 2	6,986	6,887	6,946	6,983
Resistance 1	6,927	6,878	6,921	6,920
Pivot Point	6,881	6,868	6,881	6,878
Support 1	6,822	6,858	6,841	6,816
Support 2	6,776	6,849	6,816	6,773
Support 3	6,717	6,839	6,776	6,710

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%
FIIs	(-0.11) 2.68%	(0.11) 2.78%	(0.01) 2.71%	(-0.31) 2.74%	(0.11) 3.03%	(0.01) 2.89%	(0.01) 2.92%	(0.11) 2.90%	(0.11) 2.79%	(0.11) 2.73%	(0.01) 2.66%	(0.01) 2.69%	(0.01) 2.68%	(0.11) 2.70%	(0.11) 2.61%	(0.01) 2.49%	(0.11) 2.48%	(0.01) 2.38%	(0.01) 2.38%	(0.01) 2.40%
DIIs	(0.31) 6.08%	(0.21) 5.79%	(0.31) 5.55%	(0.71) 5.26%	(-0.11) 4.55%	(-0.61) 4.65%	(0.11) 5.21%	(0.11) 5.08%	(1.21) 4.99%	(1.01) 3.77%	(0.31) 2.76%	(0.51) 2.42%	(0.51) 1.91%	(0.01) 1.41%	(0.11) 1.42%	(0.01) 1.32%	(0.11) 1.30%	(0.11) 1.19%	(0.11) 1.14%	(0.01) 1.05%
Public	16.24%	16.42%	16.73%	17.00%	17.41%	17.45%	16.85%	17.02%	17.21%	18.50%	19.57%	19.89%	20.40%	20.88%	20.97%	21.19%	21.22%	21.43%	21.48%	21.55%
No. of Shareholders	29,338	29,007	31,551	32,914	34,378	32,466	27,322	27,615	27,169	29,418	29,032	32,380	38,946	42,146	45,619	49,085	53,980	57,760	62,183	66,444

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	683	579	612	559	526	480	440	408	388	383	306	311	295	285	250	236	232	232	201	198
Sales Growth % (YoY)	29.7%	20.4%	38.9%	37%	35.8%	25.4%	44%	31.2%	31.2%	34.6%	22.4%	31.7%	27.2%	22.7%	24.6%	19.4%	32.5%	10.3%	0.1%	-5.6%
Sales Growth % (QoQ)	18%	-5.4%	9.5%	6.3%	9.6%	9.1%	7.8%	5.2%	1.3%	25.2%	-1.6%	5.4%	3.5%	14%	5.9%	1.7%	-	15.4%	1.5%	-
Expenses	634	518	567	484	445	394	363	355	349	334	291	258	228	225	213	195	204	194	186	180
Operating Profit	49	61	45	75	81	86	77	53	38	49	15	53	67	60	37	41	28	38	15	18
OPM %	7	11	7	13	15	18	17	13	10	13	4.9	17	23	21	15	17	12	16	7	9
Other Income	9	5	7	1	11	10	-26	8	-49	9	10	25	8	-32	7	7	4	4	5	3
Interest	2	2	1	1	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0
Depreciation	5	6	4	3	17	18	9	9	4	4	4	4	4	4	4	3	5	4	4	4
Profit before tax	51	58	47	73	75	78	42	51	-15	54	20	73	71	23	39	44	27	37	16	16
Tax %	25	23	30	26	25	26	27	25	-22	27	23	29	25	26	26	26	26	24	30	26
Net Profit	38	45	33	54	56	58	31	38	-12	39	16	52	54	17	29	33	20	28	11	12
Net Profit Growth % (QoQ)	-15.6%	36.4%	-38.9%	-3.6%	-3.4%	87.1%	-18.4%	416.7%	-130.8%	143.8%	-69.2%	-3.7%	217.6%	-41.4%	-12.1%	65%	-28.6%	154.5%	-8.3%	-
Net Profit Growth % (YoY)	-32.1%	-22.4%	6.5%	42.1%	566.7%	48.7%	93.8%	-26.9%	-122.2%	129.4%	-44.8%	57.6%	170%	-39.3%	163.6%	175%	-	-	-	-
TTM Net Profit	170	188	201	199	183	115	96	81	95	161	139	152	133	99	110	92	71	51	23	0
EPS in Rs	15.17	17.95	13.04	21.69	22.33	23.3	12.34	15.37	-4.72	15.79	6.32	20.95	21.54	6.91	11.72	13.02	8.06	11.19	4.57	4.78

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2276	1716	1296	1003	806	814	832	728	571	544	564	517	474	390
Sales Growth %	32.6%	32.5%	29.2%	24.5%	-1%	-2.2%	14.2%	27.6%	5%	-3.6%	9%	9.1%	21.4%	-26.5%
Expenses	2014	1462	1111	838	719	678	711	657	525	506	547	528	487	459
Operating Profit	262	254	184	165	86	135	121	71	46	37	16	-11	-13	-68
OPM %	12	15	14	16	11	17	15	10	8	7	2.9	-2.2	-3	-18
Other Income	23	-56	51	-14	15	13	13	16	12	14	7	6	23	10
Interest	4	1	1	1	1	1	1	0	0	0	0	0	0	0
Depreciation	29	40	15	16	17	20	19	15	15	16	17	15	10	12
Profit before tax	252	156	220	134	83	127	114	73	44	36	6	-21	0	-70
Tax %	26	26	26	26	26	27	37	25	41	44	9	0	0	27
Net Profit	188	116	162	99	62	93	72	54	26	20	5	-21	-1	-90
Net Profit Growth %	62.1%	-28.4%	63.6%	59.7%	-33.3%	29.2%	33.3%	107.7%	30%	300%	123.8%	-2000%	98.9%	-
EPS in Rs	75.01	46.3	64.6	39.72	24.64	37.32	28.88	21.78	10.36	8.02	2.1	-8.34	-0.2	-35.81
Dividend Payout %	48	69	37	40	41	5	3	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	-15	65	28	58	101	105	87	55	9	38	57	-46	-1	-6
Cash from Investing Activity	19	31	22	18	5	173	-171	4	-9	0	-4	-19	-15	-16
Cash from Financing Activity	-92	-66	-44	-24	-9	-9	-6	0	0	0	-1	0	86	-10
Net Cash Flow	-88	31	5	52	96	269	-90	59	-1	38	53	-64	71	-32

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5	5
Reserves	868	794	765	674	707	584	506	451	359	296	242	218	151	146	167	95
Borrowings	111	35	36	17	5	7	9	12	12	0	0	0	0	0	0	0
Other Liabilities	1006	781	712	545	362	389	337	306	330	261	214	193	247	261	244	206
Total Liabilities	1989	1615	1518	1241	1078	985	857	775	706	562	461	415	403	412	416	306
Fixed Assets	117	40	64	69	67	69	74	81	72	75	75	87	97	101	94	25
CWIP	0	0	0	0	0	1	2	4	24	7	4	5	6	12	9	74
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	1872	1575	1454	1172	1011	915	780	690	611	480	382	324	299	298	312	208
Total Assets	1989	1615	1518	1241	1078	985	857	775	706	562	461	415	403	412	416	306

Delivery

Delivery Data: ASTRAZEN

#	Date	6835 25% 8510	Value (Cr)	Q/T 19	Del 63	Del 53
1	4-Sep	6944	5	2	47	2
2	3-Sep	6940	3	3	52	1
3	2-Sep	6868	3	2	52	2
4	1-Sep	6917	2	3	53	1
5	31-Aug	6952	9	5	76	7
6	28-Aug	7106	2	3	53	1
7	27-Aug	7136	5	3	54	2
8	26-Aug	7153	2	3	52	1
9	25-Aug	7146	11	5	67	7
10	24-Aug	7232	38	7	70	27
11	21-Aug	7416	14	4	58	8
12	20-Aug	7507	7	2	52	4
13	19-Aug	7500	40	16	91	37
14	18-Aug	7645	6	3	40	2
15	17-Aug	7640	14	7	72	10
16	14-Aug	7753	4	3	48	2
17	13-Aug	7792	4	4	64	3
18	12-Aug	7906	4	4	59	2
19	11-Aug	7946	5	4	50	3
20	10-Aug	8090	39	4	30	12
21	7-Aug	8191	2	3	44	1
22	6-Aug	8076	3	3	40	1
23	5-Aug	8108	6	5	33	2
24	4-Aug	8210	4	3	44	2
25	3-Aug	8300	11	3	37	4
26	31-Jul	8100	110	36	96	106
27	30-Jul	8094	1	2	58	1
28	29-Jul	8185	5	5	64	3
29	28-Jul	8072	1	2	36	1
30	27-Jul	8168	5	4	55	3
31	24-Jul	8006	11	7	73	8
32	23-Jul	7872	3	2	55	2
33	22-Jul	8031	3	3	53	1
34	21-Jul	8088	4	5	62	3
35	20-Jul	8054	5	3	50	2
36	17-Jul	8024	7	5	50	4
37	16-Jul	8086	5	3	40	2
38	15-Jul	8228	7	3	60	4
39	14-Jul	8198	5	2	49	2
40	13-Jul	8291	10	3	51	5
41	10-Jul	8118	4	4	55	2
42	9-Jul	8114	2	3	62	1
43	8-Jul	8141	4	3	54	2
44	7-Jul	8204	3	3	53	2
45	6-Jul	8236	1	2	46	1
46	3-Jul	8310	4	3	55	2
47	2-Jul	8242	3	2	69	2
48	1-Jul	8176	5	3	56	3
49	30-Jun	8226	5	4	56	3
50	29-Jun	8058	42	4	65	27

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	17,440c	140c	0.81
03-Sep	17,300c	30c	0.17
01-Sep	17,330c	295c	1.67
31-Aug	17,625c	140c	0.79
27-Aug	17,765c	200c	1.11
26-Aug	17,965c	114c	0.64
25-Aug	17,851c	174c	0.96
24-Aug	18,025c	660c	3.53
21-Aug	18,685c	65c	0.35
19-Aug	18,750c	303c	1.59
18-Aug	19,053c	73c	0.38
17-Aug	19,125c	200c	1.03
14-Aug	19,325c	460c	2.32
13-Aug	19,785c	80c	0.41
12-Aug	19,705c	813c	3.96
10-Aug	20,518c	261c	1.29
06-Aug	20,256c	268c	1.30
05-Aug	20,524c	4c	0.02
04-Aug	20,520c	270c	1.33
31-Jul	20,250c	125c	0.61
30-Jul	20,375c	175c	0.87
29-Jul	20,200c	1c	0.01
28-Jul	20,199c	76c	0.38
27-Jul	20,275c	275c	1.38
24-Jul	20,000c	0	0

Stock Checklist

Price is above from 52 week high low average: 3%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 59 fund scheme(s) across 9 fund house(s) as of Aug26 · Total value ₹2,708 Cr · 12 increasing / 34 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	4	0.67%	-0.07%	1173.6
ICICI Prudential Mutual Fund	26	0.57%	+0.35%	797.6
Bandhan Mutual Fund	12	0.49%	-0.09%	528
Baroda BNP Paribas Mutual Fund	8	2.07%	+0.04%	146.8
UTI Mutual Fund	2	0.62%	-0.03%	34.3
ICICI Prudential Asset Management Company Limited	1	0.29%	-0.01%	27.5
Motilal Oswal Mutual Fund	2	0.03%	-0.01%	0
Navi Mutual Fund	2	0.00%	-0.79%	0
Bajaj Finserv Mutual Fund	2	0.00%	-0.76%	0

AstraZeneca Pharma India Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements